Momecutan (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Momecutan, is a corticosteroid presented as a topical formulation for cutaneous use. It is employed to manage inflammatory skin disorders such as psoriasis, eczema, contact dermatitis and seborrheic dermatitis in patients requiring localized anti‑inflammatory therapy.

GNH USA supplies Momecutan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Momecutan is a topical corticosteroid indicated for inflammatory dermatoses. It helps control symptoms and improve skin appearance.

- Psoriasis: reduces scaling, erythema and plaque thickness. - Eczema (atopic dermatitis): alleviates itching, redness and inflammation. - Contact dermatitis: diminishes allergic skin reactions and swelling. - Seborrheic dermatitis: controls flaking and irritation on scalp and face.

Topical application of Momecutan may be associated with local adverse reactions.

Common Side Effects: - Skin irritation or burning sensation. - Itching or pruritus at the application site. - Dryness or peeling of the skin.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Secondary bacterial, fungal or viral infections. - Adrenal suppression when large areas are treated extensively. - Hypersensitivity reactions such as rash or urticaria. - Systemic Cushingoid features in extreme cases.

Momecutan should be used with caution and according to professional guidance.

- Avoid application on infected, ulcerated or broken skin: may worsen infection. - Limit duration and surface area: prolonged use on large areas can increase systemic absorption. - Use sparingly in children: higher risk of growth suppression and systemic effects. - Do not combine with occlusive dressings unless directed: can enhance drug penetration. - Store at room temperature: keep in the original container, protect from moisture and light.

Topical corticosteroids can interact with other agents affecting skin integrity or systemic steroid load.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug concentration. - Immunosuppressants: heightened susceptibility to skin infections.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial creams: may alter absorption. - Phototherapy: additive skin irritation possible. - Live vaccines: potential reduction in vaccine efficacy when extensive skin areas are treated.